Dr Reddys Laboratories (RDY) EBITDA Margin Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) EBITDA Margin Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | -2,010.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 399.00 |
| Mar 31, 2021 | -488.00 |
| Sep 30, 2020 | 150.00 |
| Jun 30, 2020 | 168.00 |
| Mar 31, 2020 | -229.00 |
| Sep 30, 2019 | -2,826.00 |
| Jun 30, 2019 | 195.00 |
| Mar 31, 2019 | 772.00 |
| Dec 31, 2018 | 569.00 |
| Sep 30, 2018 | -869.00 |
| Dec 31, 2017 | -591.00 |
| Sep 30, 2017 | 441.00 |
| Dec 31, 2016 | 1,347.00 |
| Sep 30, 2016 | 1,918.00 |
| Dec 31, 2015 | -1,578.00 |
| Sep 30, 2015 | -2,246.00 |
| Dec 31, 2014 | -560.00 |
| Sep 30, 2014 | 2,246.00 |
| Mar 31, 2014 | 26.00 |
| Dec 31, 2013 | 2,138.00 |